Global Scopolamine Market presents an extensive analysis of the current Scopolamine market trends, growth drivers and restraints with respect to the various applications. The study also provides a competitive insight of major participants operating in the market. The analysts forecast global Scopolamine market to grow at a CAGR in excess of 8% over 2019-2030. North America is estimated to be the largest region for Scopolamine demand with a share around 66% followed by Europe, Asia Pacific and Middle East & Africa respectively.
ADL Pharma Ltd, Alkaloids, Inc, GlaxoSmithKline plc, Kyowa Hakko Kirin Co., Ltd, Forest Laboratories Incorporated, JW Pharmaceuticals Corporation , King Pharmaceuticals, LLC .
The study provides insights about the factors that are driving and restraining the global Scopolamine market. The research also outlines the various opportunities in this market on a global level.
- Growing demand for anti-epileptic drugs (AEDs) due to increase in incidences of epilepsy cases and age-related neurological disorders, especially Alzheimer’s disease is expected to fuel demand for Scopolamine in North America over 2019-2030. This region is estimated to occupy a share around 66% over the predicted period. The growth momentum is attributed to increasing prevalence rates of neurological disorders such as Alzheimer’s disease and epilepsy which increases patient pool size for AEDs, thereby propelling demand for Scopolamine. According to International Agency for Research on Cancer (IARC), incidence rates of dementia across 30 countries grew by 10% between 2008 and 2016 which augurs well for growth prospects in North America over 2019-2030. Growing aging population coupled with limited treatment options poses an opportunity at regional level as it will propel increase in incidences of neurologic disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s Disease among others that would necessitate usage of AED drugs increasing demand for Scopolamine globally .However stringent regulations imposed by regulatory authorities such as FDA can restrain its progress on regional front respectively; compliance with strict regulatory guidelines may hamper business expansion which might lead to decreased market share; moreover availability of generic substitutes may reduce prices that may inhibit growth prospect vis a vis overall revenue generation from sales during forecast period . Nevertheless high production capacity coupled with high distribution coverage has been identified as major driver fuelling growth prospects globally , Aurobindo Pharma Ltd, Bristol-Myers Squibb, Bayer AG, Merck & Co. Inc, Novartis International AG.
Global Scopolamine Market is segmented into North America, Europe, Asia Pacific and Middle East & Africa. Among these regions North America is estimated to be the largest market for Scopolamine as it accounts for a share of 66% in the global market. Factors such as high prevalence of diseases in this region and growth potential are expected to drive the demand for Scopolamine in North America. Europe is estimated to have the second largest share with 22% followed by Asia Pacific with a share of 17%.
Industry Growth Insights published a new data on “Scopolamine Market”. The research report is titled “Scopolamine Market research by Types (Scopolamine Butylbromide, Scopolamine Hydrobromide, Scopolamine Base), By Applications (Oral, Injection, Patches), By Players/Companies Alkaloids of Australia, Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Scopolamine Market Research Report
By Type
Scopolamine Butylbromide, Scopolamine Hydrobromide, Scopolamine Base
By Application
Oral, Injection, Patches
By Companies
Alkaloids of Australia, Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Scopolamine Market Report Segments:
The global Scopolamine market is segmented on the basis of:
Types
Scopolamine Butylbromide, Scopolamine Hydrobromide, Scopolamine Base
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral, Injection, Patches
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alkaloids of Australia
- Centroflora-cms
- Fine Chemicals Corporation
- Phytex Australia
- Alchem International
- Guangzhou Hanfang
- Alkaloids Corporation
- Luyin
Highlights of The Scopolamine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Scopolamine Butylbromide
- Scopolamine Hydrobromide
- Scopolamine Base
- By Application:
- Oral
- Injection
- Patches
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Scopolamine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Scopolamine is a medication that is used to treat motion sickness. It works by blocking the action of certain chemicals in the brain that are responsible for causing nausea and vomiting.
Some of the major players in the scopolamine market are Alkaloids of Australia, Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin.
The scopolamine market is expected to grow at a compound annual growth rate of 8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Scopolamine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Scopolamine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Scopolamine Market - Supply Chain
4.5. Global Scopolamine Market Forecast
4.5.1. Scopolamine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Scopolamine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Scopolamine Market Absolute $ Opportunity
5. Global Scopolamine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Scopolamine Market Size and Volume Forecast by Type
5.3.1. Scopolamine Butylbromide
5.3.2. Scopolamine Hydrobromide
5.3.3. Scopolamine Base
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Scopolamine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Scopolamine Market Size and Volume Forecast by Application
6.3.1. Oral
6.3.2. Injection
6.3.3. Patches
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Scopolamine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Scopolamine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Scopolamine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Scopolamine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Scopolamine Demand Share Forecast, 2019-2026
9. North America Scopolamine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Scopolamine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Scopolamine Market Size and Volume Forecast by Application
9.4.1. Oral
9.4.2. Injection
9.4.3. Patches
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Scopolamine Market Size and Volume Forecast by Type
9.7.1. Scopolamine Butylbromide
9.7.2. Scopolamine Hydrobromide
9.7.3. Scopolamine Base
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Scopolamine Demand Share Forecast, 2019-2026
10. Latin America Scopolamine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Scopolamine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Scopolamine Market Size and Volume Forecast by Application
10.4.1. Oral
10.4.2. Injection
10.4.3. Patches
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Scopolamine Market Size and Volume Forecast by Type
10.7.1. Scopolamine Butylbromide
10.7.2. Scopolamine Hydrobromide
10.7.3. Scopolamine Base
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Scopolamine Demand Share Forecast, 2019-2026
11. Europe Scopolamine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Scopolamine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Scopolamine Market Size and Volume Forecast by Application
11.4.1. Oral
11.4.2. Injection
11.4.3. Patches
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Scopolamine Market Size and Volume Forecast by Type
11.7.1. Scopolamine Butylbromide
11.7.2. Scopolamine Hydrobromide
11.7.3. Scopolamine Base
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Scopolamine Demand Share, 2019-2026
12. Asia Pacific Scopolamine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Scopolamine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Scopolamine Market Size and Volume Forecast by Application
12.4.1. Oral
12.4.2. Injection
12.4.3. Patches
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Scopolamine Market Size and Volume Forecast by Type
12.7.1. Scopolamine Butylbromide
12.7.2. Scopolamine Hydrobromide
12.7.3. Scopolamine Base
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Scopolamine Demand Share, 2019-2026
13. Middle East & Africa Scopolamine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Scopolamine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Scopolamine Market Size and Volume Forecast by Application
13.4.1. Oral
13.4.2. Injection
13.4.3. Patches
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Scopolamine Market Size and Volume Forecast by Type
13.7.1. Scopolamine Butylbromide
13.7.2. Scopolamine Hydrobromide
13.7.3. Scopolamine Base
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Scopolamine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Scopolamine Market: Market Share Analysis
14.2. Scopolamine Distributors and Customers
14.3. Scopolamine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Alkaloids of Australia
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Centroflora-cms
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fine Chemicals Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Phytex Australia
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Alchem International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Guangzhou Hanfang
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alkaloids Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Luyin
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
